GlobalData on MSN13h
EC approves Otsuka and Lundbeck’s Rxulti for schizophreniaThe decision was supported by a randomised, six-week, placebo-controlled trial involving 316 adolescent subjects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback